Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)
Clinical trial NCT07711223 · RECRUITING
Trial details
- NCT number
- NCT07711223
- Sponsor
- Jiangsu Aidea Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2028-08-31
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.